PUBLISHER: Allied Market Research | PRODUCT CODE: 1225058
PUBLISHER: Allied Market Research | PRODUCT CODE: 1225058
The shockwave therapy market was valued for $1,171.19 million in 2021 and is estimated to reach $2,269.63 million by 2031, exhibiting a CAGR of 6.8% from 2022 to 2031. Shockwave therapy is a non-invasive treatment that involves creating a series of low-energy acoustic wave pulsations that are directly applied to an injury through a person's skin via a gel medium. It can relieve pain and promote the healing of injured tendons, ligaments, and other soft tissues. These sound waves produce a therapeutic effect that causes a decrease in pain, thus increasing mobility and functionality by triggering the body's healing process. Shockwave therapy is sometimes referred to as extracorporeal pulse activation technology (EPAT).
The Food and Drug Administration has approved the use of extracorporeal shock wave therapy (ESWT) for the treatment of plantar fasciopathy and tendinopathy. However, multiple high-quality randomized clinical trials have provided substantial evidence that ESWT is a safe and effective noninvasive option for treating tendinopathy throughout the musculoskeletal system.
The key factor that drives the growth of the shockwave therapy market is the increase in the number of sports-tournament that are organized worldwide, which increases the number of sports-related injuries to a great extent. These sports injuries require speedy recovery along with faster pain relief. Moreover, rise in rates of bone diseases as well as an increase in the prevalence of musculoskeletal disorders such as arthritis, and the surge in the geriatric population are the major factors driving the growth of the market. For instance, according to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation. Furthermore, increased investments in R&D for the development of medical devices as well as rise in technological advancements and modernization in the healthcare industry may open up new market potential for shockwave therapy.
However, the high cost of the treatment by shockwave therapy and the side effects following the therapy hamper the market growth. Conversely, the surge in sedentary lifestyle practices in developing countries that are followed in the post-covid phase is giving rise to chronic spinal ailments and back problems, which provides lucrative opportunities for the growth of the market. In addition, an increase in the number of cardiovascular diseases as a result of sedentary lifestyle practices is expected to boost the growth of the market during the forecast period.
The shockwave therapy market is segmented on the basis of technology, type, application, end-user, and region. By technology, the market is fragmented into electrohydraulic shockwaves, electromagnetic shockwaves, piezoelectric shockwaves, and radial shockwaves. By product, it is bifurcated into mobile and fixed. By application, it is classified into urology, orthopedic, cardiology, and others. By end user, the market is categorized into hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the shockwave therapy market share in 2021 and is anticipated to remain dominant during the forecast period. The shockwave therapy market is mainly driven by the presence of well-established healthcare facilities, a growing geriatric population, and the rising prevalence of sports-related injuries & cardiovascular disorders. Moreover, an increase in the prevalence of arthritis and musculoskeletal disorders contribute to the market growth in the region. Furthermore, increasing investment by pharmaceutical companies in R&D activities to design technologically advanced medical devices through innovative research is expected to fuel the market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of a rapidly growing geriatric population, rising incidence of road accidents & chronic disorders, and improvement in the healthcare infrastructure are set to drive the market in Asia-Pacific.
The key players that operate in the shockwave therapy market are BioMed India, Boston Scientific Corporation, BTL Corporate, Dornier MedTech, EDAP TMS, EMS Dolorclast, Inceler Medikal Co. Ltd, Karl Storz SE & Co, SANUWAVE and SANUWAVE Health, Inc. and Shockwave Medical Inc.
Key Benefits For Stakeholders
By Technique
By Product
By End User
By Application
By Region